conophylline and Liver-Neoplasms

conophylline has been researched along with Liver-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for conophylline and Liver-Neoplasms

Article	Year
Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68. Molecular cancer therapeutics, 2021, Volume: 20, Issue:6 Treatment of hepatocellular carcinoma (HCC) is currently challenging. Cancer-associated fibroblasts (CAFs) promote the malignancy of HCC cells via production of cytokines. Conophylline (CnP), a vinca alkaloid obtained from Topics: Animals; Cancer-Associated Fibroblasts; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Mice; Receptors, G-Protein-Coupled; Vinca Alkaloids	2021

Article

Year

Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68.

Molecular cancer therapeutics, 2021, Volume: 20, Issue:6

Treatment of hepatocellular carcinoma (HCC) is currently challenging. Cancer-associated fibroblasts (CAFs) promote the malignancy of HCC cells via production of cytokines. Conophylline (CnP), a vinca alkaloid obtained from

Topics: Animals; Cancer-Associated Fibroblasts; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Mice; Receptors, G-Protein-Coupled; Vinca Alkaloids

2021